top of page
Image by Radission US

Business Development

At TIVMEK, we support our partners in identifying, evaluating, and advancing business development and in-licensing opportunities. Our team provides scientific and strategic assessments of potential assets, including clinical differentiation, competitive landscape analysis, and KOL input. By combining deep therapeutic expertise with commercial insight, we help partners make informed decisions that strengthen portfolios and maximize long-term value.

Asset Evaluation and Due Diligence

Conduct comprehensive assessments of potential licensing candidates, including scientific, clinical, regulatory, and commercial viability.

Competitive Landscape Analysis

Map therapeutic and market landscapes to identify differentiation opportunities and assess competitive positioning.

Clinical and Scientific Review

Evaluate product data, clinical trial outcomes, and unmet medical needs to determine strategic fit and growth potential.

In-Licensing and Out-Licensing Support

Facilitate partnership discussions, prepare technical and strategic briefing materials, and support contract negotiation.

Valuation and Opportunity Assessment

Integrate clinical, commercial, and market access insights to model asset value and forecast market performance.

KOL Input and Validation

Engage key opinion leaders to gather external validation and strengthen the scientific and commercial rationale for potential deals

Strategic Partnership Development

Identify and connect with potential partners or investors aligned with your business goals and therapeutic focus

.

.

Get in Touch

Montreal, QC

Canada

Thanks for submitting!

Copyright©2025 Tivmek BioPharma Inc.  All Rights Reserved

bottom of page